Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,175 | 83 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $97.21 | 6 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $62.50 | 5 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $62.17 | 5 | $0 (2022) |
| Ironwood Pharmaceuticals, Inc | $51.61 | 4 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $49.66 | 3 | $0 (2019) |
| Grifols USA, LLC | $47.67 | 4 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $40.42 | 3 | $0 (2024) |
| GENZYME CORPORATION | $39.59 | 3 | $0 (2023) |
| Horizon Therapeutics plc | $38.55 | 3 | $0 (2023) |
| Merck Sharp & Dohme LLC | $36.51 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $165.54 | 11 | Amgen Inc. ($29.55) |
| 2023 | $220.87 | 15 | Horizon Therapeutics plc ($26.09) |
| 2022 | $58.49 | 4 | Bayer HealthCare Pharmaceuticals Inc. ($18.36) |
| 2021 | $23.24 | 1 | Merck Sharp & Dohme Corporation ($23.24) |
| 2020 | $144.73 | 9 | AstraZeneca Pharmaceuticals LP ($42.50) |
| 2019 | $251.36 | 18 | AstraZeneca Pharmaceuticals LP ($39.20) |
| 2018 | $175.68 | 14 | Ironwood Pharmaceuticals, Inc ($27.23) |
| 2017 | $134.64 | 11 | Respiratory Technologies, Inc. ($24.08) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/10/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Cardio-renal | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Respiratory | ||||||
| 05/22/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: NEUROLOGY | ||||||
| 05/21/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Inflammation | ||||||
| 05/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/03/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEPHROLOGY | ||||||
| 01/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Biological | ||||||
| 12/12/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Genetic Disease | ||||||
| 12/05/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/28/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: KRYSTEXXA | ||||||
| 11/21/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.58 | General |
| 10/03/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/18/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $13.57 | General |
| 09/11/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Diabetes Care | ||||||
| 08/29/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Pulmonology | ||||||
| 08/28/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 08/18/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.50 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/04/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Central Nervous System | ||||||
| 05/02/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.38 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 1,877 | 5,929 | $522,561 | $148,698 |
| 2022 | 37 | 1,907 | 4,369 | $407,858 | $113,045 |
| 2021 | 39 | 2,252 | 5,573 | $500,173 | $143,646 |
| 2020 | 37 | 2,171 | 6,950 | $562,954 | $146,636 |
All Medicare Procedures & Services
150 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 52 | 3,540 | $180,823 | $64,700 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 172 | 287 | $104,396 | $21,989 | 21.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 129 | 129 | $52,371 | $16,631 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 64 | 77 | $39,511 | $9,544 | 24.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $11,171 | $4,002 | 35.8% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 24 | 24 | $3,558 | $3,432 | 96.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $8,830 | $2,790 | 31.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 35 | 36 | $2,662 | $2,583 | 97.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 175 | 282 | $7,772 | $2,328 | 30.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 130 | 165 | $16,454 | $2,141 | 13.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 162 | 198 | $15,569 | $2,047 | 13.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 33 | $8,515 | $1,867 | 21.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 36 | $6,460 | $1,690 | 26.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 91 | 154 | $6,856 | $1,506 | 22.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 159 | 191 | $10,461 | $1,440 | 13.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 56 | 79 | $7,687 | $1,284 | 16.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 41 | $1,730 | $1,226 | 70.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 34 | 36 | $6,314 | $1,044 | 16.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 70 | 108 | $5,462 | $1,009 | 18.5% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 24 | 24 | $975.60 | $956.16 | 98.0% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 64 | 65 | $6,521 | $784.90 | 12.0% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 12 | 12 | $492.00 | $478.56 | 97.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 39 | 51 | $3,211 | $422.79 | 13.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 21 | 21 | $2,287 | $397.32 | 17.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $716.24 | $388.83 | 54.3% |
About Dr. Bithika Ray, M.D
Dr. Bithika Ray, M.D is a Internal Medicine healthcare provider based in Mankato, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2009. The National Provider Identifier (NPI) number assigned to this provider is 1871725804.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bithika Ray, M.D has received a total of $1,175 in payments from pharmaceutical and medical device companies, with $165.54 received in 2024. These payments were reported across 83 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($1,175).
As a Medicare-enrolled provider, Ray has provided services to 8,207 Medicare beneficiaries, totaling 22,821 services with total Medicare billing of $552,025. Data is available for 4 years (2020–2023), covering 150 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Mankato, MN
- Active Since 08/09/2009
- Last Updated 07/15/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871725804
Products in Payments
- LOKELMA (Drug) $70.17
- Livalo (Drug) $62.17
- KRYSTEXXA (Biological) $52.93
- JYNARQUE (Drug) $40.42
- Rayaldee (Drug) $36.93
- Prolastin-C Liquid (Biological) $36.92
- Kerendia (Drug) $36.06
- Veltassa (Drug) $31.73
- JARDIANCE (Drug) $29.93
- LUPKYNIS (Drug) $28.49
- IBSRELA (Drug) $28.44
- LINZESS (Drug) $27.23
- RAYALDEE (Drug) $25.57
- MD cobas Instruments and Reagents (Device) $25.13
- DIFICID (Drug) $23.24
- ELIQUIS (Drug) $23.14
- PRALUENT ALIROCUMAB INJECTION (Biological) $20.03
- FREESTYLE LIBRE 3 (Device) $19.75
- INTELLIS ADAPTIVESTIM (Device) $18.06
- Veozah (Drug) $17.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mankato
Birendra Kumar, Md, MD
Internal Medicine — Payments: $7,664
Sandeep Khosa, Md, MD
Internal Medicine — Payments: $6,125
Eric Storvick, Md, MD
Internal Medicine — Payments: $1,144
Manpreet Kanwar, Md, MD
Internal Medicine — Payments: $778.13
Gregory Byrd, Do, DO
Internal Medicine — Payments: $521.11
Dr. David Byrd, Md, MD
Internal Medicine — Payments: $483.28